Industry News Portal
Industry News & Updates
Forbes-style industry coverage — trending stories, featured news, live DRAP regulatory updates, e-services, and categories with search.
IVP Expo 2027
Regulations & DRAP
Drug Regulatory Authority of Pakistan
Live regulatory updates, official e-services, application forms, and industry tools from dra.gov.pk. Relevant for veterinary pharmaceutical manufacturers, importers, and distributors.
PVPA & DRAP News
15 Aug 2026 · PVPA Secretariat
PVPA Congratulates Dr Obaidullah, CEO DRAP, on Sitara-e-Imtiaz
On behalf of PVPA leadership and Executive Members — a proud moment for Animal Health and Public Health in Pakistan.
Read full message & view posterMore PVPA & DRAP coverage
Last synced 2 Nov 2026 · 47 regulatory updates indexed
Online Portals
Industry Tools
Registered Drugs Index
Search registered drug products and manufacturers in Pakistan.
Drug Pricing Index
Official maximum retail prices and pricing notifications.
List of Pharmaceutical Units
Licensed pharmaceutical manufacturing and import units.
Medicine Availability
National medicine availability status and shortage monitoring.
Reporting & Facilitation
Public Medicine Shortage Reporting
Report medicine shortages from pharmacies and the public.
Hospital Medicine Shortage Reporting
Hospital and institutional shortage reporting portal.
Focal Person Nomination
Nominate focal persons for drug availability coordination.
Safety Reporting
Adverse drug reaction and pharmacovigilance reporting.
Facilitation Desk
Industry queries, guidance, and regulatory facilitation.
Complaints
Submit complaints regarding therapeutic goods and services.
Forms, Guidelines & Resources
Application Forms
Downloadable registration, licensing, and compliance forms.
Regulatory Procedures
Step-by-step DRAP regulatory procedures for industry.
Regulatory Fees
Official fee schedules for DRAP services and registrations.
Guidelines
Technical and procedural guidelines for manufacturers.
Newsletters
DRAP newsletters and periodic industry communications.
Recall Alerts
Product recall notices and safety alerts.
Contact DRAP
Official contact details and office locations.
DRAP Regulatory Updates
Decision of Enlistment Evaluation Committee (EEC) regarding revocation of provisional firm enlistment (Form-6) of M/s Nutris Lab, Lahore due to shifting of facility to new premises
General
Mandatory Sourcing Requirements for Active Pharmaceutical Ingredients (APIs)/Drug Substances (DS) Imported for Product Development, Stability Studies and Commercial Manufacturing
General
Training Session on MDMC Licensing and Product Registration Portal on: https://www.facebook.com/OfficialDRAP/
Medical Devices
DRAP Newsletter: Volume 03-Issue -II, November, 2024
General
DRAP Finalized Guidelines on Standards for Establishment of Hospital Pharmacies
General
DRAP invited Stakeholders Comments on revision of Guidelines on Recall of Defective Therapeutic Goods
Drugs
Warning To Therapeutic Goods Manufactures on DEG/EG Impurities in Raw Materials: A Serious Threat to Therapeutic Goods Quality and Safety
General
Registration Board Direction; Procedure for Capacity Assessment of the Contract Acceptor
Drugs
DRAP Added New eService for Online Data Submission for Registration of Pharmaceutical and Biological Product
Drugs
Training on Pakistan Single Window for DRAP Module
Drugs
Relocation of Manufacturing Units from Residential Area to Industrial Area
General
Notification: Application on Form-5F (CTD) for Extension in the Contract Manufacturing Permission of Drugs.
Drugs
Updated Database of Pharmaceutical and Biological Drug Product
Drugs
DRAP invites Comments on Draft Guidance Document for Submission of Application on Form 5F (CTD) for Registration of Biological Drug Products for Human Use
Drugs
Stakeholders' Comments are invited on the Draft Guidelines on Patient Information Leaflet
General
Med Safety App Updates; Mobile Application for Reporting of Adverse Drug Reaction is Updated and Improved
General
Safety Alert: WHO Global Alert on Tetracycline Hydrochloride Ophthalmic Ointment USP 1%
General
DRAP issued Consolidated Guidance Document on Good Manufacturing Practices for Manufacturing Sites of Drugs.
Drugs
Notification: Directions of Registration Board on Labeling Requirements of Drug Products to Comply Pharmacopeial Specifications for Dissolution Testing
Drugs
Stakeholders Comments are invited on the Draft Guidelines on Good Manufacturing Practices (GMP)
General
DRAP Newsletter: Volume 02-Quarter 01, 2023
General
Testing of Diethylene Glycol (DEG) & Ethylene Glycol (EG) at Central Drug Laboratory, Karachi
Drugs
Revocation/Cancellation of Form-6 (Provisional Certificate for Enlistment as manufacturer/importer) & Form-7(Provisional Certificate for Enlistment of products)
General
Decisions of 52nd Meeting of Medical Device Board (Deficiency letters Local/Import)
General
Rapid Alert: Drug Product; Falsified Tablin 300mg Capsule identified in the market
General
Recall Alert: Drug Product; Ponstan Forte 500mg Tablets (Batch # 2050533) by M/s Pfizer Pakistan Ltd, Karachi.
General
Recall Alert: Drug Product; Diamicron 80mg Tablets (Batch#1740) by M/s. Servier Research & Pharmaceuticals Pakistan (Pvt) Ltd Lahore.
General
Drug Safety Alert: Risk of Kidney Injury and Death due to Hydroxyethyl-Starch Solutions for Infusion.
General
Drug Safety Alert: Risk of Major Congenital Malformations with Pregabalin
General
Rapid Alert: Drug Product; Falsified Xanax 0.5mg Tablets identified in the market
General
DRAP finalized guidelines on Post Registration Variations of Pharmaceutical and Biological Drug Products
Drugs
Stakeholder Comments are invited on the Draft Therapeutic Goods (Federal Inspectors, Laboratories and Federal Government Analysts) Rules, 2022
General
Suspected Falsified Alert; Drug Products; Suspected Anti-D Immunoglobulin Injection in the market
General
Regulatory Update / Advisory; Recall of Targocid 200mg powder for solution for injection/infusion or oral solution in UK
General
DRAP finalizes Guidelines on the Preparation of Summary of Product Characteristics (SmPC)
Drugs
Notification: Applications for Registrations of Pharmaceutical drugs submitted on Form 5/5D requiring submission of Product Stability Data
Drugs
DRAP issued Guidelines on Management of High Alert Medication
General
Policy for Inspection of Manufacturing Site Abroad
Drugs
Proposed amendments in the Rules : DRAP invites comments from stakeholders and public on the draft amendments in the Drugs (Licensing, Registering and Advertising) Rules, 1976;
Drugs
National Pharmacovigilance Centre, DRAP intends to seek comments of Stakeholders on “Draft Guidelines on High Alert Medication Management”
General
DRAP invites comments of stakeholders on the draft Guidelines on Good Distribution Practices for Pharmaceutical and Biological Products
Drugs
DRAP issues guidance on the submissions of Clinical Trials Applications
Clinical Trials
DRAP issues final Guidance document for applicants on Import and Export permissions of therapeutic goods in the country
General
DRAP notified the Pharmacovigilance Rules, 2022, for active monitoring of safety of therapeutic goods across the country
General
National Pharmacovigilance Centre, DRAP issued draft guidelines on promoting Pharmacovigilance activities in Public Health Programs (PHPs).
General
DRAP issues a guidance for Healthcare Professionals on reporting of Adverse Events to the Pharmacovigilance Centers
General
DRAP asks stakeholders to comment on the draft guidelines on Bio-availability & Bio-equivalence studies for generic drug products
Drugs
Animal Health as the Productivity Infrastructure of LIVE
Congratulations to Mr. Nadeem Yousaf on Appointment as LCCI Standing Committee Convener
Pakistan Takes Important Step Against AMR in Poultry: PVPA Congratulates Government, ICARS and Research Partners
Dr. Asim Mahmood Khan, Chairman PVPA, Chairs a Grand Meeting at PVPA House for IVP Expo 2027
Featured News
Animal Health as the Productivity Infrastructure of LIVE
PVPA argues that animal health should be integrated into PIVOT's existing LIVE livestock value stream, as the productivity foundation for traceability, certification and exports.
8 min · 02/11/2026
Congratulations to Mr. Nadeem Yousaf on Appointment as LCCI Standing Committee Convener
PVPA congratulates member Mr. Nadeem Yousaf on his appointment as Convener of the LCCI Standing Committee on Veterinary Pharma for 2026–27.
PVPA NewsPakistan Takes Important Step Against AMR in Poultry: PVPA Congratulates Government, ICARS and Research Partners
PVPA, a custodian of food safety and food security, welcomes the Ministry of National Food Security & Research and ICARS initiative and will work alongside the Government in support of it.
Sponsored article
Place your company story in this Forbes-style news feed.
Trending Stories
Animal Health as the Productivity Infrastructure of LIVE
PVPA News
Congratulations to Mr. Nadeem Yousaf on Appointment as LCCI Standing Committee Convener
PVPA News
Decision of Enlistment Evaluation Committee (EEC) regarding revocation of provisional firm enlistment (Form-6) of M/s Nutris Lab, Lahore due to shifting of facility to new premises
Regulationsdra.gov.pk
Mandatory Sourcing Requirements for Active Pharmaceutical Ingredients (APIs)/Drug Substances (DS) Imported for Product Development, Stability Studies and Commercial Manufacturing
Regulationsdra.gov.pk
97 latest stories
Pakistan Takes Important Step Against AMR in Poultry: PVPA Congratulates Government, ICARS and Research Partners
PVPA, a custodian of food safety and food security, welcomes the Ministry of National Food Security & Research and ICARS initiative and will work alongside the Government in support of it.
8 min · 29/10/2026
Download PDF